MOTIVATION: During the past decade, we have seen an exponential growth of vast amounts of genetic data generated for complex disease studies. Currently, across a variety of complex biological problems, there is a strong trend towards the integration of data from multiple sources. So far, candidate gene prioritization approaches have been designed for specific purposes, by utilizing only some of the available sources of genetic studies, or by using a simple weight scheme. Specifically to psychiatric disorders, there has been no prioritization approach that fully utilizes all major sources of experimental data. RESULTS: Here we present a multi-dimensional evidence-based candidate gene prioritization approach for complex diseases and demonstrate it in schizophrenia. In this approach, we first collect and curate genetic studies for schizophrenia from four major categories: association studies, linkage analyses, gene expression and literature search. Genes in these data sets are initially scored by category-specific scoring methods. Then, an optimal weight matrix is searched by a two-step procedure (core genes and unbiased P-values in independent genome-wide association studies). Finally, genes are prioritized by their combined scores using the optimal weight matrix. Our evaluation suggests this approach generates prioritized candidate genes that are promising for further analysis or replication. The approach can be applied to other complex diseases. AVAILABILITY: The collected data, prioritized candidate genes, and gene prioritization tools are freely available at http://bioinfo.mc.vanderbilt.edu/SZGR/.
MOTIVATION: During the past decade, we have seen an exponential growth of vast amounts of genetic data generated for complex disease studies. Currently, across a variety of complex biological problems, there is a strong trend towards the integration of data from multiple sources. So far, candidate gene prioritization approaches have been designed for specific purposes, by utilizing only some of the available sources of genetic studies, or by using a simple weight scheme. Specifically to psychiatric disorders, there has been no prioritization approach that fully utilizes all major sources of experimental data. RESULTS: Here we present a multi-dimensional evidence-based candidate gene prioritization approach for complex diseases and demonstrate it in schizophrenia. In this approach, we first collect and curate genetic studies for schizophrenia from four major categories: association studies, linkage analyses, gene expression and literature search. Genes in these data sets are initially scored by category-specific scoring methods. Then, an optimal weight matrix is searched by a two-step procedure (core genes and unbiased P-values in independent genome-wide association studies). Finally, genes are prioritized by their combined scores using the optimal weight matrix. Our evaluation suggests this approach generates prioritized candidate genes that are promising for further analysis or replication. The approach can be applied to other complex diseases. AVAILABILITY: The collected data, prioritized candidate genes, and gene prioritization tools are freely available at http://bioinfo.mc.vanderbilt.edu/SZGR/.
Authors: Patrick F Sullivan; Benjamin M Neale; Edwin van den Oord; Michael F Miles; Michael C Neale; Cynthia M Bulik; Peter R Joyce; Richard E Straub; Kenneth S Kendler Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2004-04-01 Impact factor: 3.568
Authors: M A van Driel; K Cuelenaere; P P C W Kemmeren; J A M Leunissen; H G Brunner; Gert Vriend Journal: Nucleic Acids Res Date: 2005-07-01 Impact factor: 16.971
Authors: M Y M Ng; D F Levinson; S V Faraone; B K Suarez; L E DeLisi; T Arinami; B Riley; T Paunio; A E Pulver; P A Holmans; M Escamilla; D B Wildenauer; N M Williams; C Laurent; B J Mowry; L M Brzustowicz; M Maziade; P Sklar; D L Garver; G R Abecasis; B Lerer; M D Fallin; H M D Gurling; P V Gejman; E Lindholm; H W Moises; W Byerley; E M Wijsman; P Forabosco; M T Tsuang; H-G Hwu; Y Okazaki; K S Kendler; B Wormley; A Fanous; D Walsh; F A O'Neill; L Peltonen; G Nestadt; V K Lasseter; K Y Liang; G M Papadimitriou; D G Dikeos; S G Schwab; M J Owen; M C O'Donovan; N Norton; E Hare; H Raventos; H Nicolini; M Albus; W Maier; V L Nimgaonkar; L Terenius; J Mallet; M Jay; S Godard; D Nertney; M Alexander; R R Crowe; J M Silverman; A S Bassett; M-A Roy; C Mérette; C N Pato; M T Pato; J Louw Roos; Y Kohn; D Amann-Zalcenstein; G Kalsi; A McQuillin; D Curtis; J Brynjolfson; T Sigmundsson; H Petursson; A R Sanders; J Duan; E Jazin; M Myles-Worsley; M Karayiorgou; C M Lewis Journal: Mol Psychiatry Date: 2008-12-30 Impact factor: 15.992
Authors: Jan Freudenberg; Annette T Lee; Katherine A Siminovitch; Christopher I Amos; David Ballard; Wentian Li; Peter K Gregersen Journal: Hum Mol Genet Date: 2010-07-16 Impact factor: 6.150
Authors: A S Cristino; S M Williams; Z Hawi; J-Y An; M A Bellgrove; C E Schwartz; L da F Costa; C Claudianos Journal: Mol Psychiatry Date: 2013-02-26 Impact factor: 15.992
Authors: Jingchun Sun; Peilin Jia; Ayman H Fanous; Edwin van den Oord; Xiangning Chen; Brien P Riley; Richard L Amdur; Kenneth S Kendler; Zhongming Zhao Journal: PLoS One Date: 2010-06-29 Impact factor: 3.240